Literature DB >> 29369684

Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study.

Ravi Kalhan1,2, Mark T Dransfield3, Laura A Colangelo2, Michael J Cuttica1, David R Jacobs4, Bharat Thyagarajan5, Raul San Jose Estepar6, Rola Harmouche6, Jorge Onieva Onieva6, Samuel Y Ash6,7, Yuka Okajima6, Carlos Iribarren8, Stephen Sidney8, Cora E Lewis9, David M Mannino10, Kiang Liu2, Lewis J Smith1,2, George R Washko6,7.   

Abstract

RATIONALE: There are limited data on factors in young adulthood that predict future lung disease.
OBJECTIVES: To determine the relationship between respiratory symptoms, loss of lung health, and incident respiratory disease in a population-based study of young adults.
METHODS: We examined prospective data from 2,749 participants in the CARDIA (Coronary Artery Risk Development in Young Adults) study who completed respiratory symptom questionnaires at baseline and 2 years later and repeated spirometry measurements over 30 years.
MEASUREMENTS AND MAIN RESULTS: Cough or phlegm, episodes of bronchitis, wheeze, shortness of breath, and chest illnesses at both baseline and Year 2 were the main predictor variables in models assessing decline in FEV1 and FVC from Year 5 to Year 30, incident obstructive and restrictive lung physiology, and visual emphysema on thoracic computed tomography scan. After adjustment for covariates, including body mass index, asthma, and smoking, report of any symptom was associated with -2.71 ml/yr excess decline in FEV1 (P < 0.001) and -2.18 in FVC (P < 0.001) as well as greater odds of incident (prebronchodilator) obstructive (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.14) and restrictive (OR, 1.40; 95% CI, 1.09-1.80) physiology. Cough-related symptoms (OR, 1.56; 95% CI, 1.13-2.16) were associated with greater odds of future emphysema.
CONCLUSIONS: Persistent respiratory symptoms in young adults are associated with accelerated decline in lung function, incident obstructive and restrictive physiology, and greater odds of future radiographic emphysema.

Entities:  

Keywords:  chronic obstructive pulmonary disease; respiratory epidemiology; respiratory function tests; respiratory symptoms

Mesh:

Year:  2018        PMID: 29369684      PMCID: PMC6835093          DOI: 10.1164/rccm.201710-2108OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   30.528


  31 in total

1.  Smoking habit, respiratory symptoms and lung function in young adults.

Authors:  Isabel Urrutia; Alberto Capelastegui; José María Quintana; Nerea Muñiozguren; Xavier Basagana; Jordi Sunyer
Journal:  Eur J Public Health       Date:  2005-04       Impact factor: 3.367

2.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

3.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

4.  Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-11

5.  The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms.

Authors:  I B Tager; M R Segal; F E Speizer; S T Weiss
Journal:  Am Rev Respir Dis       Date:  1988-10

6.  ATS statement--Snowbird workshop on standardization of spirometry.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1979-05

7.  Identification of early interstitial lung disease in smokers from the COPDGene Study.

Authors:  George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu
Journal:  Acad Radiol       Date:  2009-09-24       Impact factor: 3.173

8.  Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis.

Authors: 
Journal:  Lancet       Date:  1965-04-10       Impact factor: 79.321

9.  Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation.

Authors:  A E Camilli; B Burrows; R J Knudson; S K Lyle; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1987-04

10.  The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.

Authors:  James P Allinson; Rebecca Hardy; Gavin C Donaldson; Seif O Shaheen; Diana Kuh; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2016-03-15       Impact factor: 21.405

View more
  29 in total

1.  Analysis of maximal expiratory flow-volume curves in adult survivors of preterm birth.

Authors:  Yannick Molgat-Seon; Paolo B Dominelli; Carli M Peters; Jordan A Guenette; A William Sheel; Igor M Gladstone; Andrew T Lovering; Joseph W Duke
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-21       Impact factor: 3.619

2.  Update in Chronic Obstructive Pulmonary Disease 2018.

Authors:  Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

3.  Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.

Authors:  Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

Review 4.  Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine.

Authors:  Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

5.  Generic Respiratory Symptoms and Branded Lung Diseases. Same Difference?

Authors:  Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 6.  Fifty Years of Progress in the Epidemiology of Chronic Obstructive Pulmonary Disease: A Review of National Heart, Lung, and Blood Institute-Sponsored Studies.

Authors:  David M Mannino
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

7.  Inflammation and endothelial activation in early adulthood are associated with future emphysema: the CARDIA Lung Study.

Authors:  J Michael Wells; Laura A Colangelo; Lakshmi Sivarajan; Bharat Thyagarajan; Mark T Dransfield; Carlos Iribarren; Paul A Reyfman; David R Jacobs; George R Washko; Ravi Kalhan
Journal:  Eur Respir J       Date:  2019-01-17       Impact factor: 16.671

8.  Journal Club-Respiratory Impairment With A Preserved Spirometric Ratio.

Authors:  Takudzwa Mkorombindo; Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

9.  Neighborhood Socioeconomic Deprivation in Young Adulthood and Future Respiratory Health: The CARDIA Lung Study.

Authors:  Sneha Thatipelli; Kiarri N Kershaw; Laura A Colangelo; Penny Gordon-Larsen; David R Jacobs; Mark T Dransfield; Daniel Meza; Sharon R Rosenberg; George R Washko; Trisha M Parekh; Mercedes R Carnethon; Ravi Kalhan
Journal:  Am J Med       Date:  2021-09-09       Impact factor: 4.965

10.  Study protocol for a national cohort of adults focused on respiratory health: the American Lung Association Lung Health Cohort (ALA-LHC) Study.

Authors:  Paul A Reyfman; Elizabeth Sugar; Heather Hazucha; Jenny Hixon; Curt Reynolds; Sonali Bose; Mark T Dransfield; MeiLan K Han; Raul San Jose Estepar; Mary B Rice; George R Washko; Mercedes Carnethon; Ravi Kalhan
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.